Quantbot Technologies LP Merus N.V. Transaction History
Quantbot Technologies LP
- $3.24 Billion
- Q3 2025
A detailed history of Quantbot Technologies LP transactions in Merus N.V. stock. As of the latest transaction made, Quantbot Technologies LP holds 1,210 shares of MRUS stock, worth $116,256. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,210Holding current value
$116,256% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding MRUS
# of Institutions
251Shares Held
68.5MCall Options Held
266KPut Options Held
483K-
Paradigm Biocapital Advisors LP New York, NY4.28MShares$411 Million10.51% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.54MShares$340 Million4.56% of portfolio
-
Commodore Capital LP New York, NY3.53MShares$339 Million17.29% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$325 Million4.09% of portfolio
-
Hbk Investments L P Dallas, TX2.85MShares$274 Million3.71% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $4.41B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...